Single Amino Acid Substitutions in the Chemotactic Sequence of Urokinase Receptor Modulate Cell Migration and Invasion

PLoS ONE

Volumn 7, Issue 9, 2012, Pages

  Bifulco, Katia ^a   Longanesi Cattani, Immacolata ^a   Franco, Paola ^b   Pavone, Vincenzo ^c   Mugione, Pietro ^a   Di Carluccio, Gioconda ^a   Masucci, Maria Teresa ^a   Arra, Claudio ^a   Pirozzi, Giuseppe ^a   Stoppelli, Maria Patrizia ^b   Carriero, Maria Vincenza ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

^b INSTITUTE OF GENETICS AND BIOPHYSICS ADRIANO BUZZATI TRAVERSO   (Italy)

^c UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN KINASE B; UROKINASE RECEPTOR; VITRONECTIN;

ACTIN FILAMENT; AMINO ACID SUBSTITUTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CYTOSKELETON; EMBRYO; ENZYME PHOSPHORYLATION; FEMALE; HUMAN; HUMAN CELL; INTERNALIZATION; LUNG METASTASIS; MOUSE; NONHUMAN; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; WOUND HEALING;

AMINO ACID SUBSTITUTION; ANIMALS; CELL ADHESION; CELL LINE, TUMOR; CELL MOVEMENT; CELL SHAPE; GENE EXPRESSION; HEK293 CELLS; HUMANS; INTEGRIN ALPHAVBETA3; MICE; MICE, NUDE; NEOPLASM INVASIVENESS; PHOSPHORYLATION; PLASMIDS; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTORS, FORMYL PEPTIDE; RECEPTORS, UROKINASE PLASMINOGEN ACTIVATOR; SIGNAL TRANSDUCTION; TRANSFECTION; VITRONECTIN;

MUS MUSCULUS;

EID: 84866708012     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0044806     Document Type: Article

References (50)

1. Smith HW, Marshall CJ, (2010) Regulation of cell signaling by uPAR. Nat Rev Mol Cell Biol 11: 23-36.
2. Pantel K, Brakenhoff RH, (2004) Dissecting the metastatic cascade. Nat Rev Cancer 4: 448-56.
3. Blasi F, Carmeliet P, (2002) uPAR: a versatile signaling orchestrator. Nat Rev Mol Cell Biol 3: 932-43.
4. Carriero MV, Stoppelli MP, (2011) The urokinase-type plasminogen activator and the generation of inhibitors of urokinase activity and signalling. Curr Pharm Des 17: 1944-61.
5. Ploug M, Rønne E, Behrendt N, Jensen AL, Blasi F, et al. (1991) Cellular receptor for urokinase plasminogen activator. Carboxyl-terminal processing and membrane anchoring by glycosyl-phosphatidylinositol. J Biol Chem 266: 1926-33.
6. Ploug M, Ellis V, (1994) Structure-function relationships in the receptor for urokinase-type plasminogen activator. Comparison to other members of the Ly-6 family and snake venom alpha-neurotoxins. FEBS Lett 349: 163-8.
7. Kjaergaard M, Hansen LV, Jacobsen B, Gardsvoll H, Ploug M, (2008) Structure and ligand interactions of the urokinase receptor (uPAR). Front Biosci 13: 5441-61.
8. Ellis V, Scully MF, Kakkar VV, (1989) Plasminogen activation initiated by single-chain urokinase-type plasminogen activator. Potentiation by U937 monocytes. J Biol Chem 264: 2185-8.
9. Sidenius N, Blasi F, (2003) The urokinase plasminogen activator system in cancer: recent advances and implications for prognosis and therapy. Cancer Metastasis Rev 22: 205-22.
10. Gyetko MR, Aizenberg D, Mayo-Bond L, (2004) Urokinase-defi cient and urokinase receptor-defi cient mice have impaired neutrophil antimicrobial activation in vitro. J Leukoc Biol 76: 648-56.
11. Selleri C, Montuori N, Ricci P, Visconte V, Carriero MV, et al. (2005) Involvement of the urokinase-type plasminogen activator receptor in hematopoietic stem cell mobilization. Blood 105: 2198-205.
12. Lund LR, Green KA, Stoop AA, Ploug M, Almholt K, et al. (2006) Plasminogen activation independent of uPA and tPA maintains wound healing in gene-deficient mice. EMBO J 25: 2686-97.
13. Eden G, Archinti M, Furlan F, Murphy R, Degryse B, (2011) The urokinase receptor interactome. Curr Pharm Des 17: 1874-89.
14. Wei Y, Lukashev M, Simon DI, Bodary SC, Rosenberg S, et al. (1996) Regulation of integrin function by the urokinase receptor. Science 273: 1551-5.
15. Carriero MV, Del Vecchio S, Franco P, Potena M, Botti G, et al. (1997) Vitronectin binding to urokinase receptor in human breast cancer. Clin Cancer Res 3: 1299-308.
16. Kjøller L, Hall A, (2001) Rac mediates cytoskeletal rearrangements and increased cell motility induced by urokinase-type plasminogen activator receptor binding to vitronectin. J Cell Biol 152: 1145-57.
17. Carriero MV, Del Vecchio S, Capozzoli M, Franco P, Fontana L, et al. (1999) Urokinase receptor interacts with alpha(v)beta5 vitronectin receptor, promoting urokinase-dependent cell migration in breast cancer. Cancer Res 59: 5307-14.
18. Franco P, Vocca I, Carriero MV, Alfano D, Cito L, et al. (2006) Activation of urokinase receptor by a novel interaction between the connecting peptide region of urokinase and (alpha)v(beta)5 integrin. J Cell Sci 119: 3424-34.
19. Fazioli F, Resnati M, Sidenius N, Higashimoto Y, Appella E, et al. (1997) A urokinase-sensitive region of the human urokinase receptor is responsible for its chemotactic activity. EMBO J 16: 7279-86.
20. Resnati M, Pallavicini I, Wang JM, Oppenheim J, Serhan CN, et al. (2002) The fibrinolytic receptor for urokinase activates the G protein-coupled chemotactic receptor FPRL1/LXA4R. Proc Natl Acad Sci USA 99: 1359-64.
21. Gargiulo L, Longanesi-Cattani I, Bifulco K, Franco P, Raiola R, et al. (2005) Cross-talk between fMLP and vitronectin receptors triggered by urokinase receptor-derived SRSRY peptide. J Biol Chem 280: 25225-32.
22. Bifulco K, Longanesi-Cattani I, Gala M, Di Carluccio G, Masucci MT, et al. (2010) The soluble form of urokinase receptor promotes angiogenesis through its Ser88-Arg-Ser-Arg-Tyr92 chemotactic sequence. J Thromb Haemost 8: 2789-99.
23. Furlan F, Orlando S, Laudanna C, Resnati M, Basso V, et al. (2004) The soluble D2D3(88-274) fragment of the urokinase receptor inhibits monocyte chemotaxis and integrin-dependent cell adhesion. J Cell Sci 117: 2909-16.
24. Madsen CD, Ferraris GM, Andolfo A, Cunningham O, Sidenius N, (2007) uPAR-induced cell adhesion and migration: vitronectin provides the key. J Cell Biol 177: 927-39.
25. Deng G, Curriden SA, Wang S, Rosenberg S, Loskutoff DJ, (1996) Is plasminogen activator inhibitor-1 the molecular switch that governs urokinase receptor-mediated cell adhesion and release? J Cell Biol 134: 1563-71.
26. Gårdsvoll H, Ploug M, (2007) Mapping of the vitronectin-binding site on the urokinase receptor: involvement of a coherent receptor interface consisting of residues from both domain I and the flanking interdomain linker region. J Biol Chem 282: 13561-72.
27. Bifulco K, Longanesi-Cattani I, Gargiulo L, Maglio O, Cataldi M, et al. (2008) An urokinase receptor antagonist that inhibits cell migration by blocking the formyl peptide receptor. FEBS Lett 582: 1141-6.
28. Carriero MV, Longanesi-Cattani I, Bifulco K, Maglio O, Lista L, et al. (2009) Structure-based design of an urokinase-type plasminogen activator receptor-derived peptide inhibiting cell migration and lung metastasis. Mol Cancer Ther 9: 2708-17.
29. Yuan C, Huang M, (2007) Does the urokinase receptor exist in a latent form? Cell Mol Life Sci 64: 1033-7.
30. Gårdsvoll H, Jacobsen B, Kriegbaum MC, Behrendt N, Engelholm L, et al. (2011) Conformational regulation of urokinase receptor function: impact of receptor occupancy and epitope-mapped monoclonal antibodies on lamellipodia induction. J Biol Chem 286: 33544-56.
31. Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, et al. (2000) The Protein Data Bank. Nucleic Acids Res 28: 235-42.
32. Barinka C, Parry G, Callahan J, Shaw DE, Kuo A, et al. (2006) Structural basis of interaction between urokinase-type plasminogen activator and its receptor. J Mol Biol 363: 482-95.
33. Llinas P, Le Du MH, Gardsvoll H, Dano K, Ploug M, et al. (2005) Crystal structure of the human urokinase plasminogen activator receptor bound to an antagonist peptide. EMBO J 24: 1655-63.
34. Huai Q, Zhou A, Lin L, Mazar AP, Parry GC, et al. (2008) Crystal structures of two human vitronectin, urokinase and urokinase receptor complexes. Nat Struct Mol Biol 15: 422-3.
35. Gårdsvoll H, Gilquin B, Le Du MH, Ménèz A, Jørgensen TJ, et al. (2006) Characterization of the functional epitope on the urokinase receptor. Complete alanine scanning mutagenesis supplemented by chemical cross-linking. J Biol Chem 281: 19260-72.
36. D'Alessio S, Blasi F, (2009) The urokinase receptor as an entertainer of signal transduction. Front Biosci. 14: 4575-87.
37. Montuori N, Carriero MV, Salzano S, Rossi G, Ragno P, (2002) The cleavage of the urokinase receptor regulates its multiple functions. J Biol Chem 277: 46932-9.
38. Montuori N, Bifulco K, Carriero MV, La Penna C, Visconte V, et al. (2011) The cross-talk between the urokinase receptor and fMLP receptors regulates the activity of the CXCR4 chemokine receptor. Cell Mol Life Sci 68: 2453-67.
39. Flores SC, Lu LJ, Yang J, Carriero N, Gerstein MB, (2007) Hinge Atlas: relating protein sequence to sites of structural flexibility BMC Bioinformatics. 8: 167.
40. Gårdsvoll H, Kjaergaard M, Jacobsen B, Kriegbaum MC, Huang M, et al. (2011) Mimicry of the regulatory role of urokinase in lamellipodia formation by introduction of a non-native interdomain disulfide bond in its receptor. J Biol Chem 286: 43515-26.
41. Xu X, Gårdsvoll H, Yuan C, Lin L, Ploug M, et al. (2012) Crystal structure of the urokinase receptor in a ligand-free form. J Mol Biol 416: 629-41.
42. Hellriegel C, Caiolfa VR, Corti V, Sidenius N, Zamai M, (2011) Number and brightness image analysis reveals ATF-induced dimerization kinetics of uPAR in the cell membrane. FASEB J 25: 2883-97.
43. Selleri C, Montuori N, Ricci P, Visconte V, Baiano A, et al. (2006) In vivo activity of the cleaved form of soluble urokinase receptor: a new hematopoietic stem/progenitor cell mobilizer. Cancer Res 66: 10885-90.
44. Rescher U, Danielczyk A, Markoff A, Gerke V, (2002) Functional activation of the formyl peptide receptor by a new endogenous ligand in human lung A549 cells. J Immunol 169: 1500-4.
45. McCoy R, Haviland DL, Molmenti EP, Ziambaras T, Wetsel RA, et al. (1995) N-formylpeptide and complement C5a receptors are expressed in liver cells and mediate hepatic acute phase gene regulation. J Exp Med 182: 207-17.
46. Kim MK, Min do S, Park YJ, Kim JH, Ryu SH, et al. (2007) Expression and functional role of formyl peptide receptor in human bone marrow-derived mesenchymal stem cells. FEBS Lett 581: 1917-22.
47. Huang J, Chen K, Chen J, Gong W, Dunlop NM, et al. (2010) The G-protein-coupled formylpeptide receptor FPR confers a more invasive phenotype on human glioblastoma cells. Br J Cancer 102: 1052-60.
48. Gavins FN, (2010) Are formyl peptide receptors novel targets for therapeutic intervention in ischaemia-reperfusion injury? Trends Pharmacol Sci 31: 266-76.
49. Mazar AP, Ahn RW, O'Halloran TV, (2011) Development of novel therapeutics targeting the urokinase plasminogen activator receptor (uPAR) and their translation toward the clinic. Curr Pharm Des 17: 1970-8.
50. Silvestri I, Longanesi Cattani I, Franco P, Pirozzi G, Botti G, et al. (2002) Engaged urokinase receptors enhance tumor breast cell migration and invasion by upregulating alpha(v)beta5 vitronectin receptor cell surface expression. Int J Cancer 102: 562-71.